SEP 30 - OCT 1, 2015
Cancer Research and Oncology
52 162 68911

Blah BlahWelcome to LabRoots’ 3rd Annual Cancer Research & Oncology free online conference!  The event is now available on-demand and you can attend sessions including keynotes sessions by Dr. Judd Moul, Dr. Kenneth Buetow, Dr. David Albala, and Dr. Herbert Lepor. This premier cancer research conference makes it easier and more cost-effective for the cancer research community to come together online to learn about recent advances in cancer research. The conference has proven to be a great success in disseminating knowledge and encouraging collaboration and connections between colleagues. Attendees can earn free CME and CE Credits.

This event will include two Mini-Symposiums. The first symposium will be focused on different areas of Prostate Cancer including prostate MRI; active surveillance and focal therapy, molecular markers in prostate cancer, what's new in robotics and minimally invasive therapy for prostate cancer and prostate disease, biomarker-guided therapy, and innovative prostate cancer therapeutics. The second symposium will be focused on different areas of Melanoma including immunotherapies, prevention and detection, caregiving and advocacy, and surviving melanoma.

There will also be multiple presentations from experts on the Innovations in Cancer Immunotherapy, Targeted, Precision Cancer Therapies for Advanced Disease, Detection of Rare Cancer Mutations and Implications for Treatment, Cancer Metabolomics, and Novel applications for the "Liquid Biopsy" or Circulating Tumor DNA assays to monitor disease and better predict Clinical Outcomes for Cancer patients.

This event will bring together research scientists, post docs, principal investigators, lab directors and professionals from around the world to learn about recent advances in cancer research. This conference offers an amazing opportunity as it is free to participants, and there will be no out-of-pocket expenses for travel. However, participants will still benefit from interacting with a global community of like-minded colleagues, without leaving the comfort of their office or home.

Conference participants will be able to:

  • Attend interactive live streaming video sessions
  • Have their questions answered in real-time by industry experts
  • Chat live with peers and speakers
  • Browse a virtual exhibit floor for solution providers

No crowded airports, delayed flights or expensive hotel rooms, but still the look and feel of a first-rate conference with world renowned experts. Participants also benefit from the fact that experts and vendors are more accessible, no more waiting in line to speak to someone. Think it is too good to be true? Checkout the venue and become a believer.

Use #BCLcancer to follow the conversation
 


Speakers:
  • Chief of Urology at Crouse Hospital and Medical Director for Associated Medical Professionals
  • Co-Director, Complex Adaptive Systems Initiative, Director, Transformative Healthcare Networks, Professor, School of Life Sciences, Arizona State University (ASU)
  • Principal Scientist, QIAGEN Bioinformatics
  • Director of Computational Sciences and Informatics program for Complex Adaptive Systems and Professor in the School of Life Sciences, Arizona State University
  • Marketing Director at Immunochemistry Technologies, LLC
  • Assistant Professor of Radiology, Director, Abdominal Imaging Fellowship Program, Duke University School of Medicine
  • Director of Dermatopathology (Dermatology), Associate Professor, Dermatology & Pathology, University of Colorado School of Medicine
  • Vice President, Studylog Systems
  • Director, Global Product Management, Clinical Program; QIAGEN Bioinformatics
  • Director of Research, CPI & Attending Urologist, The Urology Center of Colorado
  • Chairman of the Glickman Urological & Kidney Institute, Cleveland Clinic
  • Director, Scientific Applications: NGS & Isothermal Amplifications, QIAGEN
  • Professor, Public Health Research Institute, New Jersey Medical School, Rutgers University
  • Staff Application Scientist, Beckman Coulter Life Sciences
  • Urologist, NYU Langone Medical Center
  • Associate Professor, Molecular, Cell and Cancer Biology, University of Massachusetts Medical School
  • Assistant Professor of Urology and Population Health, NYU School of Medicine
  • Director of the Purdue Center for Drug Discovery Ralph C. Corley Distinguished Professor Department of Chemistry, Purdue University
  • Professor and Director, Division of Medical Physics and Biophysics, Director, DNA technology and SARRP pre-clinical laboratories, Brigham and Women's Hospital, Dana-Farber Cancer Institute
  • Institute Research Scientist, Institute for Applied Cancer Science at MD Anderson Cancer Center
  • Director of Education, Melanoma Research Foundation
  • James H Semans MD Professor of Surgery, Division of Urologic Surgery, , Director, Duke Prostate Center, Duke Cancer Institute, Duke University Medical Center
  • Chief Science Officer, Melanoma Research Alliance
  • Professor of Surgery, Director, Society of Urologic Oncology Program, Director, Genitourinary Program on Focal Therapy, Duke Cancer Institute, Duke University Medical Center
  • Founder and Chief Scientific Officer, Saladax Biomedical, Inc.
  • Global Product Manager, NGS, QIAGEN
  • Patient, Survivor, Advocate, and Author of the "Patient #1" blog
  • Technical Information Scientist, The Jackson Laboratory
  • Executive Director, Melanoma Research Foundation

Show Resources
Agenda
All times are Pacific Time
  • SEP 30, 2015 06:00 AM PDT
    Speaker: Christian Korfhage, PhD
  • SEP 30, 2015 06:00 AM PDT
    Speaker: Judd W Moul, MD, FACS
    SEE ABSTRACT | Continuing Education: CE
  • SEP 30, 2015 07:30 AM PDT
    Speaker: Lawrence Karsh MD FACS
    SEE ABSTRACT | Continuing Education: CE
  • SEP 30, 2015 07:30 AM PDT
    Speaker: Brian Soper, PhD
  • SEP 30, 2015 07:30 AM PDT
    Speaker: Philip Low, PhD
    SEE ABSTRACT | Continuing Education: CE
  • SEP 30, 2015 09:00 AM PDT
    Speaker: Eric Klein, MD
    SEE ABSTRACT | Continuing Education: CE
  • SEP 30, 2015 09:00 AM PDT
    Speaker: Jennifer Molina, PhD
    SEE ABSTRACT | Continuing Education: CE
  • SEP 30, 2015 10:30 AM PDT
    Rajan Gupta, MD
    Assistant Professor of Radiology, Director, Abdominal I...
    Thomas Polascik, MD
    Professor of Surgery, Director, Society of Urologic Onc...
    Stacy Loeb, MD
    Assistant Professor of Urology and Population Health, N...
  • SEP 30, 2015 10:30 AM PDT
  • SEP 30, 2015 10:30 AM PDT
  • SEP 30, 2015 12:00 PM PDT
    SEE ABSTRACT | Continuing Education: CE
    David Albala, MD
    Chief of Urology at Crouse Hospital and Medical Directo...
    Herbert Lepor, MD
    Urologist, NYU Langone Medical Center
  • SEP 30, 2015 12:00 PM PDT
    Speaker: Brian Lewis, PhD
    SEE ABSTRACT | Continuing Education: CE
  • SEP 30, 2015 01:30 PM PDT
    Speaker: Anna Barker, PhD
    SEE ABSTRACT | Continuing Education: CE
  • SEP 30, 2015 01:30 PM PDT
    Speaker: Jean-Noel Billaud, PhD
    SEE ABSTRACT | Continuing Education: CE
  • SEP 30, 2015 01:30 PM PDT
    Speaker: Fred Kramer, PhD
    SEE ABSTRACT | Continuing Education: CE
  • OCT 01, 2015 06:00 AM PDT
    Speaker: Raed Samara, PhD
  • OCT 01, 2015 07:30 AM PDT
    Speaker: Louise Perkins, PhD
    SEE ABSTRACT | Continuing Education: CE
  • OCT 01, 2015 07:30 AM PDT
    Speaker: Salvatore Salamone, PhD
  • OCT 01, 2015 09:00 AM PDT
    Timothy Turnham, PhD
    Executive Director, Melanoma Research Foundation
    Shelby Moneer, MS, CHES
    Director of Education, Melanoma Research Foundation
  • OCT 01, 2015 09:00 AM PDT
    Speaker: Anika Joeker, PhD
    SEE ABSTRACT | Continuing Education: CE
  • OCT 01, 2015 10:30 AM PDT
    How the diagnosis of melanoma is made: clinical detection/recognition and histologic/genetic assessment
    Speaker: Whitney High, MD, JD, M.Eng
  • OCT 01, 2015 10:30 AM PDT
    Speaker: Jackie Carville
    SEE ABSTRACT | Continuing Education: CE
  • OCT 01, 2015 12:00 PM PDT
    Speaker: Eric Ibsen
    SEE ABSTRACT | Continuing Education: CE
  • OCT 01, 2015 12:00 PM PDT
    Speaker: Mike Makrigiorgos, PhD, DABMP
    SEE ABSTRACT | Continuing Education: CE
  • OCT 01, 2015 12:00 PM PDT
    Speaker: T.J. Sharpe
  • OCT 01, 2015 01:30 PM PDT
    Speaker: Kenneth Buetow, PhD, FACMI
    SEE ABSTRACT | Continuing Education: CE
  • Progress in detection of rare cancer mutations and Implications for treatment
  • SEP 30, 2015 01:30 PM PDT
    Speaker: Fred Kramer, PhD
    SEE ABSTRACT | Continuing Education: CE
  • OCT 01, 2015 09:00 AM PDT
    Speaker: Anika Joeker, PhD
    SEE ABSTRACT | Continuing Education: CE
  • OCT 01, 2015 12:00 PM PDT
    Speaker: Mike Makrigiorgos, PhD, DABMP
    SEE ABSTRACT | Continuing Education: CE
  • Industry Speaker
  • SEP 30, 2015 06:00 AM PDT
    Speaker: Christian Korfhage, PhD
  • SEP 30, 2015 01:30 PM PDT
    Speaker: Jean-Noel Billaud, PhD
    SEE ABSTRACT | Continuing Education: CE
  • Prostate Cancer Mini-Symposium
  • SEP 30, 2015 10:30 AM PDT
    Rajan Gupta, MD
    Assistant Professor of Radiology, Director, Abdominal I...
    Thomas Polascik, MD
    Professor of Surgery, Director, Society of Urologic Onc...
    Stacy Loeb, MD
    Assistant Professor of Urology and Population Health, N...
  • Innovations in cancer immunotherapy
  • SEP 30, 2015 12:00 PM PDT
    Speaker: Brian Lewis, PhD
    SEE ABSTRACT | Continuing Education: CE
  • Targeted, precision therapies for advanced disease
  • SEP 30, 2015 07:30 AM PDT
    Speaker: Philip Low, PhD
    SEE ABSTRACT | Continuing Education: CE
  • SEP 30, 2015 01:30 PM PDT
    Speaker: Anna Barker, PhD
    SEE ABSTRACT | Continuing Education: CE
  • OCT 01, 2015 07:30 AM PDT
    Speaker: Salvatore Salamone, PhD
  • OCT 01, 2015 01:30 PM PDT
    Speaker: Kenneth Buetow, PhD, FACMI
    SEE ABSTRACT | Continuing Education: CE
  • Cancer Metabolism
  • SEP 30, 2015 09:00 AM PDT
    Speaker: Jennifer Molina, PhD
    SEE ABSTRACT | Continuing Education: CE
  • SEP 30, 2015 10:30 AM PDT
  • SEP 30, 2015 10:30 AM PDT
  • The "Liquid Biopsy" : applications for blood-based noninvasive cancer diagnostics
  • OCT 01, 2015 06:00 AM PDT
    Speaker: Raed Samara, PhD
  • Melanoma Mini-Symposium
  • OCT 01, 2015 07:30 AM PDT
    Speaker: Louise Perkins, PhD
    SEE ABSTRACT | Continuing Education: CE
  • OCT 01, 2015 09:00 AM PDT
    Timothy Turnham, PhD
    Executive Director, Melanoma Research Foundation
    Shelby Moneer, MS, CHES
    Director of Education, Melanoma Research Foundation
  • OCT 01, 2015 10:30 AM PDT
    How the diagnosis of melanoma is made: clinical detection/recognition and histologic/genetic assessment
    Speaker: Whitney High, MD, JD, M.Eng
  • OCT 01, 2015 12:00 PM PDT
    Speaker: T.J. Sharpe
  • Tools and Strategies for Improving Clinical trial outcomes and Predictive modeling
  • OCT 01, 2015 12:00 PM PDT
    Speaker: Eric Ibsen
    SEE ABSTRACT | Continuing Education: CE
Speakers

  • David Albala, MD
    Chief of Urology at Crouse Hospital and Medical Director for Associated Medical Professionals
    Biography
      Dr. David M. Albala graduated with a geology degree from Lafayette College in Easton, Pennsylvania. He completed his medical school training at Michigan State University and went on to complete his surgical residency at the Dartmouth-Hitchcock Medical Center. Following this, Dr. Albala was an endourology fellow at Washington University Medical Center under the direction of Ralph V. Clayman. He practiced at Loyola University Medical Center in Chicago and rose from the ranks of Instructor to full Professor in Urology and Radiology in eight years. After 10 years, he became a tenured Professor at Duke University Medical Center in North Carolina. At Duke, he was Co-Director of the Endourology fellowship and Director for the Center of Minimally Invasive and Robotic Urological Surgery. He has over 150 publications in peer-reviewed journals and has authored three textbooks in endourology and one in general urology. He serves on the editorial board for the Journal of Robotic Surgery, Journal of Endourology, Current Opinions in Urology and Urology Index and Reviews. He serves as a reviewer for eight surgical journals. At the present time he is Chief of Urology at Crouse Hospital in Syracuse, New York and Medical Director for Associated Medical Professionals. He is considered a national and international authority in laparoscopic and robotic urological surgery and has been an active teacher in this area for over 20 years. His research and clinical interests have focused on robotic urological surgery. In addition, other clinical interests include minimally invasive treatment of benign prostatic hypertrophy (BPH) and the use of fibrin sealants in surgery. He has been a Visiting Professor at numerous institutions across the United States as well as overseas in countries such as India, China, Iceland, Germany, France, Japan, Brazil, Australia, and Singapore. In addition, he has done operative demonstrations in over 32 countries and 23 states. He has trained 16 fellows in endourology and advanced robotic surgery. In addition, Dr. Albala is a past White House Fellow who acted as a special assistant to Federico Pena, Secretary of Transportation, on classified and unclassified public health related issues.
    • Anna Barker, PhD
      Co-Director, Complex Adaptive Systems Initiative, Director, Transformative Healthcare Networks, Professor, School of Life Sciences, Arizona State University (ASU)
      Biography
        Co-Director of Complex Adaptive Systems at ASU, Dr. Barker designs and implements transformative networks to enable the convergence of knowledge, innovative teams and novel funding approaches to address major problems in biomedicine. Several initiatives are underway, including: the National Biomarker Development Alliance NBDA; a program to re-think diseases that are particularly difficult to diagnose and treat; and a consortium focused on deep phenotyping in silico medicine. Prior to joining ASU, Dr. Barker served for several years as Deputy Director of the National Cancer Institute (NCI) and Deputy Director for Strategic Scientific Initiatives. At the NCI she developed and led or co-led a number of transdisciplinary programs including the: The Cancer Genome Atlas (TCGA); Nanotechnology Alliance for Cancer; Clinical Proteomics Technologies Initiative for Cancer; and the Physical Sciences- Oncology Centers (PS-OCs). She co-chaired the NCI-FDA Interagency Task Force (IOTF) and was founding co-chair of the Cancer Steering Committee of the FNIH Biomarkers Consortium (FNIH-BC). Achievements from these groups included the exploratory IND (IOTF); and oversight of the design and implementation of the ISPY-2 Trial (FNIH-BC). She served as a research scientist and a senior executive at Battelle Memorial Institute for 18 years; and subsequently co-founded and served as the CEO of a public biotechnology company. Examples of her public service include: the National Coalition of Cancer Research; Partner and Member of the Board of Directors of C-Change; Chairperson, C-Change Cancer Research Team; Founding member, Department of Defense (DOD) Breast Cancer Research Program (BCRP) and Chairperson of the Integration Panel (IP); a number of roles for the American Association for Cancer Research (AACR), including the Board of Directors and chairperson, Science Policy and Legislative Affairs Committee; member of NCIs Board of Scientific Counselors, Division of Cancer Etiology; and Chairperson, NCI Cancer Center Support Review Study Section. Dr. Barker has received a number of awards for her efforts in science and advocacy for cancer research. Her research interests include complex adaptive systems science, biomarkers, experimental therapeutics and free-radical biochemistry in cancer etiology and treatment. Dr. Barker completed her M.A. and Ph.D. at The Ohio State University, where she trained in immunology and microbiology.
      • Jean-Noel Billaud, PhD
        Principal Scientist, QIAGEN Bioinformatics
        Biography
          Jean-Noel Billaud, Ph.D. is Principal Scientist at QIAGEN Bioinformatics. He joined Ingenuity Systems (now QIAGEN) in 2008 as staff scientist for in silico research program in oncology and infectious diseases. Jean-Noel Billaud holds a Ph.D. in Blood Cell Biology from Paris VII, and has done his post-doctoral work at the Scripps Research Institute (San Diego, CA).
        • Kenneth Buetow, PhD, FACMI
          Director of Computational Sciences and Informatics program for Complex Adaptive Systems and Professor in the School of Life Sciences, Arizona State University
          Biography
            Dr. Ken Buetow is a human genetics and genomics researcher who leverages computational tools to understand complex traits such as cancer, liver disease, and obesity. Dr. Buetow currently serves as Director of Computational Sciences and Informatics program for Complex Adaptive Systems at Arizona State University (CAS@ASU) and is a professor in the School of Life Sciences in ASU's College of Liberal Arts and Sciences. CAS@ASU applies systems approaches that leverage ASU's interdisciplinary research strengths to address complex global challenges. The Computational Sciences and Informatics program is developing and applying information technology to collect, connect, and enhance trans-disciplinary knowledge both within ASU and across the broader knowledge-generating ecosystems. CAS@ASU is creating a Next Generation Cyber Capability to address the challenges and opportunities afforded by "Big Data" and the emergence of 4th Paradigm Data Science. This capability brings state-of-the-art computational approaches to CAS@ASU's transdisciplinary, use-inspired research efforts Dr. Buetow previously served as the Director of the Center for Biomedical Informatics and Information Technology within the National Institutes of Health's National Cancer Institute (NCI). In that capacity he initiated and oversaw the NCI's efforts to connect the global cancer community through community-developed, standards-based, interoperable informatics capabilities that enable secure exchange and use of biomedical data. Buetow designed and built one of the largest biomedical computing efforts in the world. He was responsible for coordinating biomedical informatics and information technology at the NCI. The NCI center he led focused on speeding scientific discovery and facilitated translational research by coordinating, developing and deploying biomedical informatics systems, infrastructure, tools and data in support of NCI research initiatives.
          • Jackie Carville
            Marketing Director at Immunochemistry Technologies, LLC
            Biography
              Jackie Carville is the Director of Marketing at ImmunoChemistry Technologies where she focuses on providing comprehensive, user-friendly content to assist life science researchers in optimizing their project pipelines. She obtained her undergraduate education at the University of Wisconsin-Madison, studying Genetics and Life Science Communication. Prior to ICT, Jackie spent several years marketing and presenting bioinformatics software tools. Jackie frequently presents in webinars and at conferences, and is passionate about offering innovative solutions to challenging technical problems.
            • Rajan Gupta, MD
              Assistant Professor of Radiology, Director, Abdominal Imaging Fellowship Program, Duke University School of Medicine
              Biography
                Dr. Rajan T. Gupta, MD, is an Assistant Professor of Radiology in the Division of Abdominal Imaging at Duke University Medical Center, as well as the Director of the Abdominal Imaging Fellowship Program and a Faculty physician in the Duke Cancer Institute. Since 2009, he has been a faculty member in the Department of Radiology at Duke. Dr. Gupta has coauthored over 40 peer-reviewed publications. He has been awarded two Duke-Coulter Translational Research Grants as Clinical Principal Investigator, the most recent of which was entitled, "Registration of Multi-parametric MR and Quantitative Shear Wave Elasticity Images for Focal Prostate Cancer Procedures." He is a member of the Duke Cancer Institute Multi-Disciplinary Prostate Cancer Strategy Group. He has been an invited Refresher Course speaker at the Radiological Society of North America national meeting for the past 5 years and has been an invited Visiting Professor at institutions such as George Washington University, MD Anderson Cancer Center, The Mayo Clinic, and the University of Chicago. His recent published works have been focused on the comparison of multiparametric MRI (mpMRI) at 3 Tesla with the Partin Tables in assessment of organ confined prostate cancer, the effects of dedicated education on reader performance of mpMRI interpretation, and the assessment/development of a novel ultrasonic technique (Acoustic Radiation Force Impulse Imaging - ARFI) in the detection/characterization of prostate cancer in conjunction with his colleagues in the Department of Biomedical Engineering at Duke.
              • Whitney High, MD, JD, M.Eng
                Director of Dermatopathology (Dermatology), Associate Professor, Dermatology & Pathology, University of Colorado School of Medicine
                Biography
                  Whitney A. High, MD, MEng, a native of Colorado, is the Director of the laboratory, and he is board-certified in Dermatology and Dermatopathology. He also has certification in Tropical Medicine & Hygiene. After practicing as a chemical engineer in industry, Dr. High returned to medical school to receive his medical degree from the Mayo Clinic School of Medicine in 2000. Dr. High completed his dermatology residency training at University of Texas Southwestern Medical Center in 2004, serving as Chief Resident, and his dermatopathology fellowship at the University of Colorado in Denver in 2005. He has also studied tropical medicine in Central and South America. Dr. High is appointed to the Departments of Dermatology & Pathology at the University of Colorado, and the Department of Chemistry at the Colorado School of Mines. He serves as the only dermatologist on faculty at the Denver STD/HIV Training Center, a clinic sponsored by the Centers for Disease Control (CDC). Dr. High also has a degree in law from the University of Denver. Dr. High has authored 2 textbooks, 12 chapters and more than 40 medical papers. He currently serves as one of the youngest editors of the Journal of the American Academy of Dermatology, and he is an editor/editorial board member of other medical journals.
                • Eric Ibsen
                  Vice President, Studylog Systems
                  Biography
                    Eric Ibsen co-founded Studylog Systems in 2003, bringing to Studylog extensive international experience in, pharmacology, animal modeling, toxicology and quality assurance in the biopharmaceutical industry. At PDL BioPharma, Ibsen conducted essential in vivo research in toxicology, oncology, inflammation and animal model development. Ibsen contributed to a successful drug discovery effort in oncology as a Scientist at Eos Biotechnology. From 1983 to 2001 he performed pharmacology research in a variety of organizations, including the Stehlin Foundation for Cancer Research, Cetus Corporation, XOMA Corporation, Bayer AG (Germany), Genentech and Theravance.
                  • Anika Joeker, PhD
                    Director, Global Product Management, Clinical Program; QIAGEN Bioinformatics
                    Biography
                      Anika Joecker is a director in the global product management department in the clinical program of QIAGEN bioinformatics. She has been working in the field of bioinformatics for the last 15 years and worked as a bioinformatics group leader at the German Cancer Research Center before she joined CLC bio, now QIAGEN in 2011.
                    • Lawrence Karsh MD FACS
                      Director of Research, CPI & Attending Urologist, The Urology Center of Colorado
                      Biography
                        Dr. Karsh has practiced Urology in Denver since 1984 and was board Certified in 1986, completing the most recent recertification in 2013. He graduated from the Chicago Medical School and completed his General Surgical training at The University of Colorado Health Sciences Center under Dr. Thomas Starzl. He completed his Urology residency at Brigham and Women's Hospital/Harvard Medical School under Dr. Ruben Gittes. Dr. Karsh is a co-founder of The Urology Center of Colorado where he serves as an attending Urologist and Director of Research. He is a principal investigator with an experience of more than 160 clinical trials. He is a Certified Principal Investigator, certified by the Association of Clinical Research Professionals (ACRP.) Dr. Karsh has authored a number of peer-reviewed publications and serves on the editorial boards for "Urologists in Cancer Care" and "Bladder Cancer." He is an active member of the AUA, ASCO, SWOG as well as the SUO. He serves on the bladder cancer subcommittee for the SUO Clinical Trials Consortium and is a member of the Denver Academy of Surgeons. Dr. Karsh serves as an advisor and consultant to the pharmaceutical industry, participating in drug development and research protocols. He educates physicians across the country about newly approved therapies. In his spare time, Dr. Karsh is an avid road bicycler and skier.
                      • Eric Klein, MD
                        Chairman of the Glickman Urological & Kidney Institute, Cleveland Clinic
                        Biography
                          Eric A. Klein, MD, is the Chairman of the Glickman Urological & Kidney Institute and a staff member in the Taussig Cancer Institute at Cleveland Clinic. His clinical interests are cancers of the prostate, testis and kidney. For several years, including the current edition, Dr. Klein is listed in Best Doctors in America. Board-certified in urology, Dr. Klein is a frequent lecturer and visiting professor at numerous national and international universities. He was the National Medical Study Coordinator for the National Cancer Institute sponsored Selenium and Vitamin E Cancer Prevention Trial (SELECT). Dr. Klein is the editor of Urology and has been the recipient of numerous awards from the American Cancer Society, the University of Pittsburgh School of Medicine, and the Cleveland Clinic. Dr. Klein received his medical degree from University of Pittsburgh School of Medicine in Pennsylvania. He completed his residency in urology at Cleveland Clinic and a fellowship in urology at the Memorial Sloan Kettering Cancer Center in New York.
                        • Christian Korfhage, PhD
                          Director, Scientific Applications: NGS & Isothermal Amplifications, QIAGEN
                          Biography
                            Dr. Christian Korfhage is Director, R&D Scientific Applications, at QIAGEN in Hilden. His responsibilities include the development and evaluation of new amplification and assay technologies and solutions for single cell research. Dr. Korfhage joined QIAGEN in 1997 and has held various positions in Research and Development in the areas of real-time PCR methods, isothermal amplification methods, and single cell technologies. After studying biology, he received his Ph.D. from the Institute of Genetics at the Faculty for Biology (University of Cologne, Germany) in 1993. He also completed postgraduate studies at the Max Planck Institute for Plant Breeding (Cologne) and the Institute of Molecular Neurology (Düsseldorf) in Germany.
                          • Fred Kramer, PhD
                            Professor, Public Health Research Institute, New Jersey Medical School, Rutgers University
                            Biography
                              Fred Russell Kramer is Professor of Microbiology and Molecular Genetics at the New Jersey Medical School, and has been a Principal Investigator at the Public Health Research Institute for the past 25 years. He graduated from the University of Michigan in 1964 and received his doctorate from the Rockefeller University in 1969. He was on the faculty of the Department of Genetics and Development at Columbia University College of Physicians and Surgeons for 17 years and has been a Research Professor and Adjunct Professor in the Department of Microbiology at New York University School of Medicine for the past 24 years.
                            • Bee Na Lee, PhD
                              Staff Application Scientist, Beckman Coulter Life Sciences
                              Biography
                                Dr. Bee Na Lee has worked at Beckman Coulter Life Sciences for five years, where she is responsible for leading microRNA and RNA applications. She has 10 years of experience in genomic and genetics research. Prior to joining Beckman Coulter, she worked at the genomic institute at Syngenta, eGene (a start-up company), and Qiagen. She was the lead scientist in developing QIAxcel Genetic Analyzer and published more than 30 application methods, protocols and application notes. She has a PhD in Microbiology and Molecular Biology from Texas A&M University, and was a postdoctoral fellow at Harvard Medical School, sponsored by Leukemia Society of America. Her research experience was in the fields of fungal biology, cell signaling, small molecules and plan pathogenicity. She has published more than 15 peer reviewed scientific papers on cell signaling, development and pathogenicity
                              • Herbert Lepor, MD
                                Urologist, NYU Langone Medical Center
                                Biography
                                  Herbert Lepor, MD, is one of the leading experts in the field of prostate cancer. He is currently the Martin Spatz Chairman of the Department of Urology and the Director of the Smilow Comprehensive Prostate Cancer Center at the NYU Langone Medical Center in New York. He was previously appointed Chairman of Urology at NYU School of Medicine at the age of 37, the youngest chairman of a major academic urology department in the country at that time. Dr. Lepor has written more than 300 articles on the topic of prostate cancer in peer-reviewed academic publications. He has made important contributions to the screening, detection, and treatment of prostate cancer.
                                • Brian Lewis, PhD
                                  Associate Professor, Molecular, Cell and Cancer Biology, University of Massachusetts Medical School
                                  Biography
                                    Brian Lewis received his B.S. in Biology from the University of California, Los Angeles in 1991, and his Ph.D. from Johns Hopkins University in 1997. He performed postdoctoral studies at the NIH and Memorial Sloan-Kettering Cancer Center, supported by a Helen Hay Whitney Foundation postdoctoral fellowship. Dr. Lewis joined the Program in Gene Function and Expression at the University of Massachusetts Medical School as an Assistant Professor in the winter of 2003. Research in Dr. Lewis' lab focuses on dissecting the molecular mechanisms underlying the development and progression of pancreatic and hepatocellular cancers, with the goal of informing effective targeted therapeutic approaches.
                                  • Stacy Loeb, MD
                                    Assistant Professor of Urology and Population Health, NYU School of Medicine
                                    Biography
                                      Dr. Stacy Loeb is an Assistant Professor of Urology and Population Health at New York University (NYU), specializing in prostate cancer. Dr. Loeb completed her urology residency training at Johns Hopkins and subsequently received a Masters of Science in Comparative Effectiveness Research at NYU. She has a K07 grant from the National Cancer Institute to study active surveillance for prostate cancer. Dr. Loeb is an internationally recognized expert in prostate cancer with more than 225 peer-reviewed published articles and 8 book chapters. She is on the Editorial Board for the British Journal of Urology International, European Urology, Urology Practice and Reviews in Urology. Dr Loeb authored the chapter on "Early Detection, Diagnosis, and Staging of Prostate Cancer" for Campbell-Walsh Urology. Dr. Loeb also frequently gives international lectures on prostate cancer, and hosts the Men's Health Show on Sirius XM 81 satellite radio.
                                    • Philip Low, PhD
                                      Director of the Purdue Center for Drug Discovery Ralph C. Corley Distinguished Professor Department of Chemistry, Purdue University
                                      Biography
                                        Dr. Philip S. Low is the Director of the Purdue University Center for Drug Discovery and the Ralph C. Corley Distinguished Professor of Chemistry. Dr. Low has spent over 39 years exploring novel methods for drug targeting, and characterizing the structure, function, and pathologies of the erythrocyte membrane. He has published >350 scientific articles and has >50 US patents/patents pending. Eight drugs stemming from his research are undergoing human clinical trials and three companies (Endocyte Inc., OnTarget Laboratories Inc., and HuLow LLC) have been founded to commercialize his discoveries. Dr. Low has received an NIH MERIT Award, the ACS Award for Cancer Research (Sosnovsky Award), the AACR Award for Outstanding Chemistry in Cancer Research, both of Purdue's awards for outstanding research (McCoy and Sigma Xi Awards), the University's highest career achievement award (Morrill Award), and numerous other National and International awards. Dr. Low received his B.S. in Chemistry from Brigham Young University (1971) and his Ph.D. in Biochemistry from UCSD (1975).
                                      • Mike Makrigiorgos, PhD, DABMP
                                        Professor and Director, Division of Medical Physics and Biophysics, Director, DNA technology and SARRP pre-clinical laboratories, Brigham and Women's Hospital, Dana-Farber Cancer Institute
                                        Biography
                                          Dr. Makrigiorgos is a Professor of Radiation Oncology and Director of the Medical Physics & Biophysics division at Dana Farber Cancer Institute and Brigham and Women's Hospitals, Harvard Medical School. He also directs the DNA technology laboratory and the radiation pre-clinical facility. His research interests include the development of novel DNA technologies for molecular diagnostics in Oncology and he identification of circulating cancer biomarkers. He is the inventor of several PCR-based techniques for molecular diagnostics, including Balanced-PCR, Anti-primer-quenching-real-time PCR, Hairpin-PCR, COLD-PCR and DiSSeCT technology. He is a Member of the Editorial Board of Clinical Chemistry and has published over 120 articles, reviews and book chapters.
                                        • Jennifer Molina, PhD
                                          Institute Research Scientist, Institute for Applied Cancer Science at MD Anderson Cancer Center
                                          Biography
                                            Dr. Jennifer Molina has a PhD in Biomedical Science from the University of Texas Graduate School of Biomedical Science, and research experience in the fields of cancer biology, biochemistry, cell signaling, and drug discovery. Dr. Molina joined the Institute for Applied Cancer Science (IACS) in 2015 following a postodoctoral fellowship in the Department of Systems Biology at MD Anderson Cancer Center, where she focused on uncovering mechanisms of metabolic adaptation in breast cancer for the discovery of potential therapeutic metabolic targets. Dr. Molina is an Institute Research Scientist in the biology division at IACS.
                                          • Shelby Moneer, MS, CHES
                                            Director of Education, Melanoma Research Foundation
                                            Biography
                                              Shelby Moneer joined the MRF team in August of 2010 to oversee the education program. As the Director of Education, Shelby is responsible for all development, implementation and assessment of the education program. This includes patient/caregiver education, clinician education, primary and secondary prevention efforts, print materials, awareness campaigns, website content, over-the-phone patient navigation and all patient resources and communication. These programs range from in-person events, virtual events and include a wide variety of print materials, all of which are free to the public. Shelby is also the manager of the MRF's research grant program. Shelby holds a bachelor's degree in Exercise Science and a master's degree in Health Education. Her previous experience was in the non-profit development, implementation and assessment of tobacco-related education, prevention and treatment strategies in the Florida Panhandle. She was a collegiate volleyball and softball player and continues playing beach volleyball whenever she can. Shelby and her husband, Steve, have a 3 year old daughter and live in Spokane, WA. They enjoy playing and watching sports, spending time outdoors and being surrounded with friends and family.
                                            • Judd W Moul, MD, FACS
                                              James H Semans MD Professor of Surgery, Division of Urologic Surgery, , Director, Duke Prostate Center, Duke Cancer Institute, Duke University Medical Center
                                              Biography
                                                Judd W. Moul is James H. Semans, MD Professor of Surgery, Division of Urologic Surgery, and Director of the Duke Prostate Center, Duke Cancer Institute at Duke University Medical Center. Prior to joining Duke, he was Professor of Surgery at the Uniformed Services University of the Health Sciences (USUHS) in Bethesda, Maryland and an attending Urologic Oncologist at the Walter Reed Army Medical Center (WRAMC) in Washington, DC. In addition, he was Director of the Center for Prostate Disease Research (CPDR); a Congress-mandated research program of the Department of Defense based at USUHS and WRAMC. In 2004, he completed a 26-year U.S. Army career, retiring as a full Colonel in the Medical Corps, and became Chief of the Division of Urologic Surgery at Duke. Serving as Chief from 2004 to 2011, he brought innovation and growth to the program. Most notably, he started the Duke Prostate Center, expanded the urology residency training program through a novel collaboration with the Department of Defense and was able to maintain Duke Urology as a top 10 program in the nation throughout his tenure. Dr Moul completed his Urologic Oncology Fellowship at Duke University and graduated Summa Cum Laude from Pennsylvania State University. He earned his medical degree from Jefferson Medical College, where he was elected to Phi Beta Kappa and Alpha Omega Alpha. Dr Moul currently serves on the editorial boards of Prostate Cancer, Prostate Cancer and Prostatic Diseases, BJU International, American Journal of Mens Health, Brazilian Journal of Urology, World Journal of Urology, and Oncology REALTIME. He has published over 500 medical and scientific manuscripts and book chapters and has lectured at national and international meetings. He has appeared on ABC, NBC, CNN, PBS, and other media as a prostate cancer authority. Honors and awards received have included the American Medical Associations Young Physicians Section Community Service Award for his national involvement in prostate cancer patient support groups, the Sir Henry Welcome Research Medal and Prize from the Association of Military Surgeons of the United States, the prestigious Gold Cystoscope Award by the American Urological Association, the Baron Dominique Jean Larrey Military Surgeon Award for Excellence, the Order of Military Medical Merit from the Surgeon General at the US Army, and the Castle Connolly National Physician of the Year award.
                                              • Louise Perkins, PhD
                                                Chief Science Officer, Melanoma Research Alliance
                                                Biography
                                                  Dr. Perkins joined the Melanoma Research Alliance as Chief Science Officer in 2013 where she is responsible for the development and implementation of the MRA's scientific strategy including its research award program and annual Scientific Retreat. Her interests center on translational research including genomics, drug discovery and advancement of novel therapeutic approaches. She became a member of the Board of Directors of the Foundation for Sarcoidosis Research in late 2015. Prior to joining the MRA, she was Chief Scientific Officer at the Multiple Myeloma Research Foundation (MMRF) for five years, following a 16-year research career at two major pharmaceutical companies. While at the MMRF, Dr. Perkins led the expansion of its venture philanthropy activities including its Biotech Investment Award program and development of the scientific direction of its CoMMpasssm longitudinal study. Prior to joining the MMRF, Dr. Perkins was Director of Cancer Research at Bayer Pharmaceuticals, where she contributed to advancing novel targeted therapies toward clinical study including Nexavar® and other innovative signal transduction inhibitors. Prior to joining Bayer, she led a cancer research group at the Schering-Plough Research Institute participating in early-stage programs, including novel target-finding using human genomics data. Dr. Perkins graduated from the University of Michigan with a PhD and MS in Biological Chemistry and conducted postdoctoral studies at Princeton University in the Department of Molecular Biology. She earned her BS in Zoology from the University of North Carolina at Chapel Hill.
                                                • Thomas Polascik, MD
                                                  Professor of Surgery, Director, Society of Urologic Oncology Program, Director, Genitourinary Program on Focal Therapy, Duke Cancer Institute, Duke University Medical Center
                                                  Biography
                                                    Thomas J. Polascik, M.D. is Professor in the Duke Cancer Institute, the Department of Surgery at the Duke University Medical Center, Durham, NC. Dr. Polascik trained at the Brady Urological Institute, the Johns Hopkins Hospital in Baltimore Maryland. After finishing his residency under the tutelage of Patrick C. Walsh M.D. he did an oncology fellowship under the mentorship of Alan W. Partin M.D. PhD. He then joined the faculty at Duke University and has been there since 1998. His clinical practice and research interests incorporate both prostate and kidney cancer. In 2006 he developed an interest in the nascent field of focal therapy for prostate cancer. He is the founder and director, the International Symposium on Focal Therapy and Imaging of Prostate and Kidney Cancer that began at Duke in 2008. The symposium has brought together investigators and clinicians from all regions of the world and the meeting alternates between North America and Europe with Co-chairs Drs Jean de la Rosette and Indy Gill. This year marked the eighth annual meeting to be held in the Netherlands in June 2015. Dr. Polascik is the Editor of Imaging and Focal Therapy of Early Prostate Cancer released in 2013. He is the director of the Society of Urologic Oncology program at Duke and also the Genitourinary Program on Focal Therapy at the Duke Cancer Institute. His research interests include the development of image-guided therapies for early prostate cancer, the development of prostate cancer imaging techniques and minimally invasive treatment options for both prostate and kidney cancer. He has published over 250 manuscripts and book chapters. He has held positions on several boards of directors, advisory boards, and has been active in the North Carolina Urological Association and the Board of Directors with the Southeastern American Urological Association. He is an avid ad hoc reviewer for a number of journals and currently holds a NIH R-O1 and Department of Defense Grant for research.
                                                  • Salvatore Salamone, PhD
                                                    Founder and Chief Scientific Officer, Saladax Biomedical, Inc.
                                                    Biography
                                                      Dr. Salamone is the founder of Saladax Biomedical which is a company dedicated to the development of TDM in the field of oncology and companion diagnostics. Saladax has supported numerous clinical studies supporting the use of TDM in oncology and has become the leading force in oncology TDM. Dr. Salamone has more than 25 years' experience in the health care and medical device industries. Prior to founding Saladax, he was Vice President of Research and Development, Roche Diagnostics, where he was responsible for North American research and development efforts for the Laboratory Systems Division. Dr. Salamone's efforts during his 17-year tenure at Roche resulted in the launch of seven major reagent product lines, comprised of more than 70 FDA-approved products and more than 200 instrument applications. Dr. Salamone is well published in the field with more than 70 peer reviewed publications, numerous book chapters and is also the holder of 42 issued US patents. He serves on the boards of several companies, is a reviewer for several scientific journals, participates on a NIH study section for SBIR-STTR grants and often is an invited speaker at major conferences. Dr. Salamone received two bachelor's degrees from Villanova University, a master's and a PhD degree from Rutgers University and was a SERC Post-Doctoral Fellow at Oxford University.
                                                    • Raed Samara, PhD
                                                      Global Product Manager, NGS, QIAGEN
                                                      Biography
                                                        Raed Samara, PhD is a Global Product Manager for NGS technologies at QIAGEN, with a focus on pre-analytics and targeted enrichment. Prior to joining QIAGEN, he was a postdoctoral fellow at the National Cancer Institute conducting research in the field of cancer immunology with emphasis on identifying strategies to boost the efficacy of cancer vaccines. He received his Ph.D. degree from Georgetown University in tumor biology.
                                                      • T.J. Sharpe
                                                        Patient, Survivor, Advocate, and Author of the "Patient #1" blog
                                                        Biography
                                                          T.J. Sharpe is sharing his fight against Stage 4 Melanoma in his weekly Patient #1 blog on www.Philly.com/Patient1. A South Jersey native and Bishop Eustace and Carnegie Mellon University graduate, he currently lives in Fort Lauderdale, FL with his wife Jennifer and children Josie and Tommy. He was Patient #1 in a clinical trial at Moffitt Cancer Center in Tampa as the first person worldwide to use this sequence of treatments to fight melanoma, and is currently in a second clinical trial at Holy Cross Hospital in Fort Lauderdale receiving Merck's anti-PD-1 drug pembrolizumab
                                                        • Brian Soper, PhD
                                                          Technical Information Scientist, The Jackson Laboratory
                                                          Biography
                                                            Brian has worked at The Jackson Laboratory for 20 years. He conducted research on treatment strategies for a mouse model of human enzyme deficiency. Approaches included enzyme replacement, gene therapy, and neonatal allogeneic bone marrow transplantation. He is currently a Technical Information Services Scientist. Brian's area of expertise is in modeling (and complications associated with) human type 1 and type 2 diabetes, and research with immunodeficient mice.
                                                          • Timothy Turnham, PhD
                                                            Executive Director, Melanoma Research Foundation
                                                            Biography
                                                              Tim Turnham became the Executive Director of the Melanoma Research Foundation (MRF) in January 2009. Tim shares the MRF's commitment to supporting medical research to find more effective treatments and eventually a cure for melanoma and brings more than 30 years of experience in management, fundraising, communication, teaching and research. Prior to joining the MRF, Tim served as Chief Executive Officer of the Colon Cancer Alliance as well as Director of Development for United Cerebral Palsy Associations. He has also served as the Director of Development for the Whitman-Walker Clinic and as Director of Development at the Children's Research Institute. Tim holds a B.A. in Microbiology from the University of Tennessee, a M. Div. from the New Orleans Baptist Theological Seminary and a Ph.D. from the Southern Baptist Theological Seminary. Tim lives in Washington, D.C. with his wife Phyllis. They have three adult children
                                                            Sponsored By

                                                            For information on becoming a sponsor or exhibitor, please click here.


                                                            Continuing Education (CME/CE/CEU) Credits

                                                            The speakers below have been approved for CME, CE, or CEU credits. To redeem your credits, locate the presentation you watched and click on the CME/CE/CEU buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here


                                                            Committee

                                                            To download the Program Committee brochure here.


                                                            • Bruce Hollis, PhD

                                                              Bruce W. Hollis, Ph.D. received his B.Sc. and M.Sc. from the Ohio State University and subsequently his Ph.D. from the University of Guelph in 1979. Dr. Hollis then completed an Endocrine Fellowship at The Case Western Reserve University School of Medicine in 1982. Dr. Hollis ...

                                                              See more See less
                                                            • Alan Maisel, MD

                                                              Dr. Alan Maisel attended University of Michigan Medical School and did his cardiology training at the University of California at San Diego. He is currently Professor of Medicine at the University and director of the coronary care unit and the heart failure program at the ...

                                                              See more See less
                                                            • Michael Holick, MD, PhD

                                                              Michael F. Holick, Ph.D., M.D. is Professor of Medicine, Physiology and Biophysics; Director of the General Clinical Research Unit; and Director of the Bone Health Care Clinic and the Director of the Vitamin D, Skin and Bone Research Laboratory at Boston University Medical ...

                                                              See more See less
                                                            • Kamisha Johnson-Davis, PhD, DABCC, FACB

                                                              Dr. Johnson-Davis is a medical director of the Clinical Toxicology laboratory, Antifungal Testing and Immunosuppressants Testing at ARUP. Dr. Johnson-Davis received her PhD in pharmacology at the University of Utah and is board certified in clinical chemistry by the American ...

                                                              See more See less
                                                            • Charles Cantor, PhD

                                                              Dr. Charles Cantor is a founder, and Chief Scientific Officer at SEQUENOM, Inc., which is a genetics discovery company with tools, information and strategies for determining the medical impact of genes and genetic variations. He is also the founder of SelectX Pharmaceuticals ...

                                                              See more See less
                                                            • Peter Blume-Jensen, MD, PhD

                                                              Dr. Peter Blume-Jensen has extensive expertise in basic and translational cancer research, oncogenic signaling, and targeted oncology therapeutics drug discovery prior to joining Metamark as CSO in 2010.  From 2001 to 2008 Peter was department head at first Serono, US and ...

                                                              See more See less
                                                            • Pinar Bayrak-Toydemir, MD, PhD

                                                              Dr. Bayrak-Toydemir is the medical director of the Molecular Genetics and Genomics Laboratories at ARUP and an associate professor of pathology at the University of Utah School of Medicine. Dr. Bayrak-Toydemir received her MD from the Ankara University School of Medicine in ...

                                                              See more See less
                                                            • Joan W Bennett, PhD

                                                            • Amy K Saenger, PhD, DABCC, FACB

                                                            • Theral Timpson

                                                            • Stephanie Willerth, PhD

                                                              Dr. Willerth currently holds a Canada Research Chair in Biomedical Engineering at the University of Victoria where she is dually appointed in the Department of Mechanical Engineering and Division of Medical Sciences. Her research group investigates how to engineer neural tissue ...

                                                              See more See less
                                                            • Mark Marzinke, PhD, BABCC

                                                              Mark Marzinke, PhD, DABCC earned a Ph.D. in Biochemistry from the University of Wisconsin-Madison and subsequently completed a clinical chemistry fellowship at The Johns Hopkins University in 2012. During his clinical fellowship, Dr. Marzinke focused on the development and ...

                                                              See more See less
                                                            • C Jimmy Lin, MD, PhD, MHS

                                                              Jimmy Lin, MD, PhD, MHS, is a 2012 TED Fellow and Founder & President of Rare Genomics Institute, the world's first platform to enable any community to leverage cutting-edge biotechnology to advance understanding of any rare disease. Partnering with 18 of the top medical ...

                                                              See more See less
                                                            • John Quackenbush, PhD

                                                              John Quackenbush received his PhD in 1990 in theoretical physics from UCLA working on string theory models. Following two years as a postdoctoral fellow in physics, Dr. Quackenbush applied for and received a Special Emphasis Research Career Award from the National Center for ...

                                                              See more See less
                                                            • Leigh Anne Swayne, PhD

                                                            • Ross J Molinaro, PhD, MT(ASCP), DABCC, FACB

                                                              Ross J. Molinaro, PhD, MT(ASCP), DABCC, FACB is an Assistant Professor in the Department of Pathology and Laboratory Medicine at Emory University. He received his PhD in Clinical Chemistry and Molecular Medicine from Cleveland State University and completed the ComACC training ...

                                                              See more See less
                                                            • Wieslaw Furmaga, MD

                                                              Director, Clinical Chemistry Laboratory University Hospital Director, General Laboratory Cancer Treatment Research Center Director, Proteomics Laboratory UTHSC at San Antonio Interim Director, Molecular Laboratory UTHSC at San Antonio Associate Director, Mycology Laboratory UTHSC ...

                                                              See more See less
                                                            • George Fritsma, MS, MT

                                                              George Fritsma is an associate professor in Laboratory Medicine of the Department of Pathology at the University of Alabama at Birmingham. Prof. Fritsma manages www.fritsmafactor.com, "The Fritsma Factor, Your Interactive Hemostasis Resource," a clinical coagulation ...

                                                              See more See less
                                                            • R. Claudio Aguilar, Ph.D.

                                                              Dr. Aguilar obtained his PhD degree in Immunochemistry from the School of Pharmacy and Biochemistry, University of Buenos Aires, Argentina. Dr. Aguilar pursued his post-doctoral training at the National institutes of Health in Bethesda, MD in the lab of the well-known cell ...

                                                              See more See less
                                                            • Joely Straseski, PhD, MS, MT(ASCP), DABCC

                                                              Dr. Straseski is a medical director of endocrinology at ARUP Laboratories and an assistant professor of pathology at the University of Utah School of Medicine. She received her PhD in pathology and laboratory medicine and a Master's degree in bacteriology from the University of ...

                                                              See more See less
                                                            • Christoph H. Borchers, Ph.D.

                                                              Dr. Borchers received his B.S., M.S. and Ph.D. from the University of Konstanz, Germany. After his post-doctoral training and employment as a staff scientist at NIEHS/NIH/RTP, NC and he was the director of the Duke - UNC Proteomics Facility and held a faculty position at UNC ...

                                                              See more See less
                                                            • Sharon Geaghan, MD

                                                              Dr. Geaghan is Chief, Pathology at Lucile Packard Children's Hospital at Stanford, and Co-Director of Clinical Laboratories at Stanford Hospital and Clinics. She also directs the Bass Pediatric Cancer Center Laboratory at the Lucile Packard Hospital; is Director of the Point of ...

                                                              See more See less
                                                            • Vincent Mauro, Ph.D.

                                                              Dr. Mauro is an Associate Professor in the Department of Neurobiology at the Scripps Research Institute in La Jolla, California. He is also a co-founder and lead scientist of Promosome, a biotechnology company focused on bioproduction enablement and DNA vaccines. In addition, Dr ...

                                                              See more See less
                                                            • Deanne Taylor, MS, PhD

                                                              Dr. Taylors background is in biophysics, bioinformatics, computational biology and structural biology with emphasis on human genetics and translational medicine. She obtained her Ph.D. in Biophysics from the University of Michigan, Ann Arbor, and completed a postdoctoral ...

                                                              See more See less
                                                            • Ariel Louwrier PhD

                                                              Successful Senior Scientific Business Executive with demonstrated expertise growing markets, revenues, product pipelines and expanding technical organizations into new business opportunities. Educational and business management experience in global markets, with quantified ...

                                                              See more See less
                                                            • Pierre-Antoine Gourraud, PhD, MPH

                                                              Pierre-Antoine Gourraud is a former student of the Ecole Normale Suprieure de Lyon in France. After receiving an M.P.H. from University Paris XIII in 2002, he got his Ph.D. in Immunogenetic Epidemiology and Public Health from Toulouse University in 2005. He relocated to the ...

                                                              See more See less
                                                            • Cynthia Bowman MD

                                                              Dr. Cynthia Bowman has been a broad based general pathologist for over 30 years. She graduated with a BA in Chemistry from St. Olaf College, received her MD from Vanderbilt University Medical School, and trained for 6 years at the University of California, San Francisco as a ...

                                                              See more See less
                                                            • Sihe Wang, PhD DABCC FACB

                                                              Dr. Sihe Wang is Section Head and Medical Director of Clinical Biochemistry and Director of Clinical Biochemistry Fellowship Training Program, Cleveland Clinic, Cleveland, Ohio. He also chairs the clinical chemistry integration effort for the Cleveland Clinic Health System which ...

                                                              See more See less
                                                            • Ottavio Arancio MD, Ph.D

                                                              Dr. Ottavio Arancio received his Ph.D and M.D. from the University of Pisa (Italy). From 1981 to 1986 he took residency training in Neurology at the University of Verona (Italy). Dr. Arancio has held Faculty appointments at Columbia University, NYU School of Medicine and at ...

                                                              See more See less
                                                            • Eric Gluck, MD, JD

                                                            • Josip Blonder, MD

                                                              Dr. Blonder leads the Clinical Proteomics Group at the CRTP/FNL. FNL is a Federally Funded Research and Development Center operated by Leidos Biomedical Research, Inc., for the National Cancer Institute (NCI). In 1978, Dr. Blonder received his M.D. at the Rijeka University ...

                                                              See more See less
                                                            • Szczepan Baran, VMD, MS

                                                              Dr. Szczepan Baran is the Global Head, Animal Welfare and Compliance Training at Novartis Institutes for Biomedical Research. Dr. Baran received a Bachelor of Science in Pre-Veterinary Medicine from the University of Delaware, a Veterinary Medical Doctoral degree from the ...

                                                              See more See less
                                                            • Agnieszka Lichanzka Ph.D.

                                                              Agnieszka is currently a Staff Scientist and Laboratory Manager at TessArae, LLC in Sterling, VA, USA. She obtained her PhD at the University of Queensland in Australia in a field of biochemistry, and subsequently worked as a post-doctoral fellow at Queen's University of Belfast ...

                                                              See more See less
                                                            • Tatjana Matejic, PhD, D(ABMLI)

                                                            • David Carpentieri, MD

                                                            • Timothy Harris, PhD

                                                              Since June 2011, Dr. Harris has served as the Senior Vice President of Translational Medicine at Biogen Idec. Dr. Harris has served as the Director of the Advanced Technology Program at SAIC Frederick since 2007 and Chief Technology Officer for SAIC Frederick since 2008. Prior to ...

                                                              See more See less
                                                            • Antonio Baines, PhD

                                                              Dr. Antonio T. Baines is an Associate Professor in the Department of Biology at North Carolina Central University (NCCU) and an adjunct professor in the Department of Pharmacology in the School of Medicine at the University of North Carolina (UNC) Chapel Hill. He earned a ...

                                                              See more See less
                                                            • Daniel Irimia, MD, PhD

                                                            • Fred Russell Kramer, PhD

                                                            • Martin Latterich, PhD

                                                              The discovery of proteinaceous disease biomarkers and their clinical validation is critically important for the enablement of molecular diagnostics and ultimately, precision medicine. In spite of the importance of biomarkers, research done in the last two decades has yielded ...

                                                              See more See less
                                                            • Judd Moul, MD, FACS

                                                              Judd W. Moul is James H. Semans, MD Professor of Surgery, Division of Urologic Surgery, and Director of the Duke Prostate Center, Duke Cancer Institute at Duke University Medical Center. Prior to joining Duke, he was Professor of Surgery at the Uniformed Services University of ...

                                                              See more See less
                                                            • Kathryn Wellen, PhD

                                                            • Howard Morris, PhD, FAACB, FFSc(RCPA)

                                                              Professor Howard Morris is Professor of Medical Sciences at the University of South Australia and a Chief Medical Scientist in Chemical Pathology at SA Pathology, Adelaide, South Australia. He is currently Vice-President of the International Federation of Clinical Chemistry ...

                                                              See more See less
                                                            • Alan Wright, MD

                                                              Dr. Wright is the Chief Medical Officer at Roche Diagnostics Corporation in Indianapolis, Indiana. Prior to joining Roche, Dr. Wright served as Senior Vice President of Health Improvement Strategies for Miraca Life Sciences. He was the Vice President for Product Strategy and ...

                                                              See more See less
                                                            • Anthony Grace, PhD

                                                              Dr. Anthony A. Grace is a Distinguished Professor of Neuroscience and a Professor of Psychiatry and Psychology at the University of Pittsburgh in Pittsburgh, PA. He received his Ph.D. from Yale University School of Medicine with Dr. Benjamin S. Bunney and had postdoctoral ...

                                                              See more See less
                                                            • Ulrich Hengst, PhD

                                                              Dr. Ulrich Hengst studied biochemistry at the Ruhr University Bochum, Germany, and conducted his graduate research at the Friedrich Miescher Institute for Biomedical Research in Basel, Switzerland, in the group of Prof. Denis Monard. In 2003 he received his PhD from the ...

                                                              See more See less
                                                            • Paul Mathews, PhD

                                                              Dr. Paul J. Mathews received his bachelors degree from the University of Oregon where he studied invertebrate behavioral plasticity in the lab of Dr. Nathan Tublitz. He received his Ph.D. in neuroscience from the University of Texas at Austin under the mentorship of Dr. Nace ...

                                                              See more See less
                                                            • Ahmad Salehi, MD, PhD

                                                              Ahmad Salehi, M.D., Ph.D. is a Clinical Associate Professor at the Department of Psychiatry and Behavioral Sciences, Stanford Medical School and the Director of the Translational Laboratory at the VA Palo Alto Health Care System in California. He obtained his MD in Tehran, Iran ...

                                                              See more See less
                                                            • Katerina Venderova, PharmD, PhD

                                                              Dr. Katerina Venderova obtained her master's and doctorate degrees in pharmacy, and her PhD in Toxicology from Charles University in the Czech Republic. She then received a fellowship from the Parkinson Society Canada and pursued her postdoctoral training at Toronto Western ...

                                                              See more See less
                                                            • Bradley Ford, MD, PhD

                                                              Bradley Ford received his M.D. and Ph.D. (Physiology and Biophysics) degrees from SUNY Stony Brook, followed by a Clinical Pathology residency and postdoctoral training in basic and clinical microbiology at Washington University in St. Louis. His research interests include ...

                                                              See more See less
                                                            • Bart C. Weimer, PhD

                                                            Help

                                                            General LabRoots Questions

                                                            For bugs, spam, technical support or questions please call +1-714-463-4673 or email support@labroots.com  
                                                            Contact us

                                                            Virtual Events and Webinars

                                                            Supported Configurations

                                                            • Operating System Internet Explorer Firefox Chrome Safari
                                                              Vista IE8+ FF10+ Chrome15+
                                                              Windows 7 IE8+ FF10+ Chrome15+
                                                              Windows 8 IE10 FF10+ Chrome15+
                                                              Mac OS X   FF10+ Chrome15+ Safari5.1+
                                                            • Cookie settings: session cookies enabled
                                                            • Browser configuration must have JavaScript enabled
                                                            • Adobe Flash player 10.2 or later

                                                            To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

                                                            Internet Connection

                                                            • A minimum of 100Kbps is recommended for audio-only events
                                                            • A minimum of 300Kbps is recommended for speaker on-video events

                                                            Computer Equipment

                                                            • Screen Resolution: Minimum 1024x768
                                                            • Video Card: 65,000 colors minimum
                                                            • Sound card and speakers (or headphones) for hearing webcast in full format
                                                            • Audio Card: 16-bit minimum
                                                            • RAM: 512MB of free RAM

                                                            Firewall Protocol

                                                            • HTTP on port 80 or HTTPS on port 443
                                                            • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
                                                            • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

                                                            Work-At-Home Attendees

                                                            • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

                                                            For A Seamless Experience

                                                            When using a mobile device, FREE Mobile Apps are available:

                                                            - For viewing Webinars:

                                                            - For viewing Virtual Events

                                                            Attendee Guide

                                                            • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

                                                            Virtual Event and Webinar Support:

                                                            Continuing Education (CME/CE) Support

                                                            Loading Comments...
                                                            Show Resources